Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000932471-25-000334·Cytosorbents Corp
Schedule 13G ownership disclosure
CYTOSORBENTS CORP
Common Stock · CUSIP: 23283X206
Event date: 2024-12-31
- Filing-level shares
- 3,899,102
- Percent of class
- 7.13%
- The Vanguard Group
Shares: 3,899,102 · Class: 7.13%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000334
- Form type
- SCHEDULE 13G
- Filer
- Cytosorbents Corp
- CIK
- CIK 1175151
- Filed
- Jan 31, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership